牛牛AI助理已提取核心訊息
Pfizer Inc. (PFE) Executive Vice President, Payal Sahni, was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. The report only confirms the involvement of a high-level executive in a recent stock transaction, which may be of interest to investors following insider activity within Pfizer.
Pfizer Inc. (PFE) Executive Vice President, Payal Sahni, was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. The report only confirms the involvement of a high-level executive in a recent stock transaction, which may be of interest to investors following insider activity within Pfizer.
據報道，輝瑞公司（PFE）執行副總裁帕亞爾·薩尼於2024年2月27日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。該報告僅證實了一位高級管理人員參與了最近的一次股票交易，在輝瑞內部活動之後，投資者可能會對該交易感興趣。
據報道，輝瑞公司（PFE）執行副總裁帕亞爾·薩尼於2024年2月27日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。該報告僅證實了一位高級管理人員參與了最近的一次股票交易，在輝瑞內部活動之後，投資者可能會對該交易感興趣。
有用
沒用